Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1966]

Progress in targeted therapy of melanoma

Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA

Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany

How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

Combining immunotherapy with stereotactic body radiotherapy

Dr James Welsh - MD Anderson Cancer Center, Houston, USA

Combining immunotherapy with stereotactic body radiotherapy ( Dr James Welsh - MD Anderson Cancer Center, Houston, USA )

Systemic immunotherapy and radiotherapy combination shows promise in advanced...

Dr Susan Hiniker - Stanford University, Stanford, USA

Systemic immunotherapy and radiotherapy combination shows promise in advanced skin cancer ( Dr Susan Hiniker - Stanford University, Stanford, USA )

Is 3D-conformational or intensity-modulated radiation therapy better for NSCLC?

Dr Stephen Chun - MD Anderson Cancer Centre, Houston, USA

Is 3D-conformational or intensity-modulated radiation therapy better for NSCLC? ( Dr Stephen Chun - MD Anderson Cancer Centre, Houston, USA )

Can early stage NSCLC be treated with stereotactic radiation therapy?

Dr David Palma – London Health Sciences Centre, London, Canada

Can early stage NSCLC be treated with stereotactic radiation therapy? ( Dr David Palma – London Health Sciences Centre, London, Canada )

Can SBRT be of use for early, operable non-small cell lung cancer?

Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA

Can SBRT be of use for early, operable non-small cell lung cancer? ( Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA )

What is the potential for using monoclonal antibodies in multiple myeloma?

Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel

What is the potential for using monoclonal antibodies in multiple myeloma? ( Prof Sagar Lonial, Prof Pieter Sonneveld, Prof Jesús San Miguel )

Expert discussion on current experience with monoclonal antibodies in multiple...

Prof Antonio Palumbo and Prof Philippe Moreau

Expert discussion on current experience with monoclonal antibodies in multiple myeloma ( Prof Antonio Palumbo and Prof Philippe Moreau )

ECC 2015: Editor's highlights

Prof Gordon McVie - ecancer Managing Editor

ECC 2015: Editor's highlights ( Prof Gordon McVie - ecancer Managing Editor )

More from ecancer